Bioethics News

Google’s Biotech Venture Hit by Ethical Concerns over Deal with Luxury Clinic

April 7, 2016

(STAT News) – Andrew Conrad, who runs Google’s ambitious biotech offshoot, successfully pushed the company to award a research contract to a luxury health clinic he largely owns that has no documented experience with this kind of work, STAT has learned. The arrangement has stirred concern inside Verily Life Sciences — and among corporate governance experts who see it as a conflict of interest.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.